Abel Hall, LLC Ocugen, Inc. Transaction History
Abel Hall, LLC
- $216 Billion
- Q2 2025
A detailed history of Abel Hall, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Abel Hall, LLC holds 14,918 shares of OCGN stock, worth $15,365. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,918
Previous 11,721
27.28%
Holding current value
$15,365
Previous $8.28 Million
74.85%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding OCGN
# of Institutions
109Shares Held
62.8MCall Options Held
200KPut Options Held
151K-
Black Rock Inc. New York, NY17.9MShares$18.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.8MShares$15.2 Million0.0% of portfolio
-
State Street Corp Boston, MA5.93MShares$6.11 Million0.0% of portfolio
-
Ubs Group Ag4.37MShares$4.5 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$4.28 Million0.16% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $223M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...